We serve 4-Cyanobenzyl bromide CAS:17201-43-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-Cyanobenzyl bromide
CAS.NO:17201-43-3
Synonyms:
4-(bromomethyl)benzonitrile
4-cyanobenzyl bromide
α-Bromo-p-tolunitrile
alpha-Bromo-p-tolunitrile
Benzonitrile, 4-(bromomethyl)-
Molecular Formula:C8H6BrN
Molecular Weight:196.04400
Physical and Chemical Properties:
Density: 1.51 g / cm3
Boiling point: 143 ° C / 12mmHg
Melting point: 115-117 ° C (lit.)
Flash point: 125.1ºC
Refractive index: 1.588
Specification:
Appearance:Off-white crystalline powder
Purity:≥99%
Loss on drying:≤0.5%
Packing:
25kg cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Alogliptin benzoate CAS:850649-62-6
Intermediates of AlogliptinCAS:850649-61-5
Contact us for information like 4-Cyanobenzyl bromide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzonitrile, 4-(bromomethyl)- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzonitrile, 4-(bromomethyl)- Use and application,4-(bromomethyl)benzonitrile technical grade,usp/ep/jp grade.
Related News: ll coronaviruses are zoonotic, meaning they are transmitted between animals and people.1-(4'-Sulfophenyl)-3-carboxy-5-pyrazolone manufacturer Under the strict supervision of environmental protection, it has helped the API industry to continuously optimize its product structure, realize industrial upgrading, and transition to the development of high-end APIs.2,3-Dihydrobenzo[b]furan-5-carbaldehyde supplier Many domestic raw material pharmaceutical and intermediate manufacturing companies with strong capital and talent reserves and advanced technology and processes have developed in the country, and the competitiveness of market participants has continued to increase.4-Bromocumene vendor In addition, a high-standard GMP workshop is under construction and is expected to be put into production within the year. As the capacity bottleneck is broken, the pharmaceutical intermediate business is expected to grow rapidly in the future, providing the company with new growth momentum.U.S. drugmaker Gilead dominates the HIV market and it will keep up the pressure with fast-growing Biktarvy, which was approved early last year.
